175 related articles for article (PubMed ID: 24691491)
1. Attenuation of malignant phenotypes of breast cancer cells through eIF2α-mediated downregulation of Rac1 signaling.
Hamamura K; Minami K; Tanjung N; Wan Q; Koizumi M; Matsuura N; Na S; Yokota H
Int J Oncol; 2014 Jun; 44(6):1980-8. PubMed ID: 24691491
[TBL] [Abstract][Full Text] [Related]
2. Suppressed invasive and migratory behaviors of SW1353 chondrosarcoma cells through the regulation of Src, Rac1 GTPase, and MMP13.
Xu W; Wan Q; Na S; Yokota H; Yan JL; Hamamura K
Cell Signal; 2015 Dec; 27(12):2332-42. PubMed ID: 26303573
[TBL] [Abstract][Full Text] [Related]
3. eIF2α-Independent Inhibition of TNF-α-Triggered NF-κB Activation by Salubrinal.
Nakajima S; Chi Y; Gao K; Kono K; Yao J
Biol Pharm Bull; 2015; 38(9):1368-74. PubMed ID: 26328492
[TBL] [Abstract][Full Text] [Related]
4. Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha.
Hamamura K; Tanjung N; Yokota H
J Bone Miner Metab; 2013 Nov; 31(6):618-28. PubMed ID: 23536193
[TBL] [Abstract][Full Text] [Related]
5. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
6. Eukaryotic initiation factor 2α--a downstream effector of mammalian target of rapamycin--modulates DNA repair and cancer response to treatment.
Tuval-Kochen L; Paglin S; Keshet G; Lerenthal Y; Nakar C; Golani T; Toren A; Yahalom J; Pfeffer R; Lawrence Y
PLoS One; 2013; 8(10):e77260. PubMed ID: 24204783
[TBL] [Abstract][Full Text] [Related]
7. Eukaryotic translation initiation factor 2 subunit α (eIF2α) inhibitor salubrinal attenuates paraquat-induced human lung epithelial-like A549 cell apoptosis by regulating the PERK-eIF2α signaling pathway.
Wang R; Sun DZ; Song CQ; Xu YM; Liu W; Liu Z; Dong XS
Toxicol In Vitro; 2018 Feb; 46():58-65. PubMed ID: 28986289
[TBL] [Abstract][Full Text] [Related]
8. Salubrinal protects against Clostridium difficile toxin B-induced CT26 cell death.
Chen S; Sun C; Gu H; Wang H; Li S; Ma Y; Wang J
Acta Biochim Biophys Sin (Shanghai); 2017 Mar; 49(3):228-237. PubMed ID: 28119311
[TBL] [Abstract][Full Text] [Related]
9. Effects of salubrinal on cadmium-induced apoptosis in HK-2 human renal proximal tubular cells.
Komoike Y; Inamura H; Matsuoka M
Arch Toxicol; 2012 Jan; 86(1):37-44. PubMed ID: 21809093
[TBL] [Abstract][Full Text] [Related]
10. Salubrinal, an eIF2α dephosphorylation inhibitor, enhances cisplatin-induced oxidative stress and nephrotoxicity in a mouse model.
Wu CT; Sheu ML; Tsai KS; Chiang CK; Liu SH
Free Radic Biol Med; 2011 Aug; 51(3):671-80. PubMed ID: 21616140
[TBL] [Abstract][Full Text] [Related]
11. Administration of salubrinal enhances radiation-induced cell death of SW1353 chondrosarcoma cells.
Koizumi M; Tanjung NG; Chen A; Dynlacht JR; Garrett J; Yoshioka Y; Ogawa K; Teshima T; Yokota H
Anticancer Res; 2012 Sep; 32(9):3667-73. PubMed ID: 22993304
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor activity of the combination of salubrinal and rapamycin against human cholangiocarcinoma cells.
Zhao X; Zhang C; Zhou H; Xiao B; Cheng Y; Wang J; Yao F; Duan C; Chen R; Liu Y; Feng C; Li H; Li J; Dai R
Oncotarget; 2016 Dec; 7(51):85492-85501. PubMed ID: 27863431
[TBL] [Abstract][Full Text] [Related]
13. Salubrinal Suppresses IL-17-Induced Upregulation of MMP-13 and Extracellular Matrix Degradation Through the NF-kB Pathway in Human Nucleus Pulposus Cells.
Yao Z; Nie L; Zhao Y; Zhang Y; Liu Y; Li J; Cheng L
Inflammation; 2016 Dec; 39(6):1997-2007. PubMed ID: 27590238
[TBL] [Abstract][Full Text] [Related]
14. Guanabenz Downregulates Inflammatory Responses via eIF2α Dependent and Independent Signaling.
Takigawa S; Chen A; Nishimura A; Liu S; Li BY; Sudo A; Yokota H; Hamamura K
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164082
[TBL] [Abstract][Full Text] [Related]
15. PERK-Phosphorylated eIF2α Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast Cancer.
Zou W; Bai Y; Wang X; Cheng K; Sun H; Zhang G; Wang X; Yang Z
Cancer Biother Radiopharm; 2017 Oct; 32(8):282-287. PubMed ID: 29053414
[TBL] [Abstract][Full Text] [Related]
16. Salubrinal-Mediated Upregulation of eIF2α Phosphorylation Increases Doxorubicin Sensitivity in MCF-7/ADR Cells.
Jeon YJ; Kim JH; Shin JI; Jeong M; Cho J; Lee K
Mol Cells; 2016 Feb; 39(2):129-35. PubMed ID: 26743901
[TBL] [Abstract][Full Text] [Related]
17. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
[TBL] [Abstract][Full Text] [Related]
18. Experimental Evidence Shows Salubrinal, an eIF2α Dephosphorylation Inhibitor, Reduces Xenotoxicant-Induced Cellular Damage.
Matsuoka M; Komoike Y
Int J Mol Sci; 2015 Jul; 16(7):16275-87. PubMed ID: 26193263
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of eIF2α dephosphorylation slow replication and stabilize latency in Toxoplasma gondii.
Konrad C; Queener SF; Wek RC; Sullivan WJ
Antimicrob Agents Chemother; 2013 Apr; 57(4):1815-22. PubMed ID: 23380722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
